PTC Therapeutics Provides a Corporate Update and Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 62.56 -0.06 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.62 | 52 Week High | $35.40 | |||
| Open | $62.62 | 52 Week Low | $4.03 | |||
| Day High | $63.49 | P/E | 6.66 | |||
| Day Low | $62.24 | EPS | $9.40 | |||
| Volume | 170,643 | |||||
